摘要
局部应用的他克莫司软膏和匹美克莫司霜是两种新的钙调磷酸酶抑制剂。作为局部免疫调节剂用于特应性皮炎的治疗。作为抗炎药其非常安全和较好疗效的特点 ,使它们成为治疗许多皮肤病的有吸引力的候选药物。已发表的文献表明它们除应用于特应性皮炎外 ,尚可用于银屑病、脂溢性皮炎。
出处
《国外医学(皮肤性病学分册)》
2003年第3期144-146,共3页
Foreign Medical Sciences(Section of Dermatology and Venereology)
参考文献13
-
1Bekersky I, Lilja H, Lawrence I. Tacrolimus pharmacology and nonclinical studies: from FK506 to protopic. Semin Cutan Med Surg,2001.20(4) :226 -232.
-
2Stuetz A, Grassberger M, Meingassner JG. Pimecrolimus ( Elidel,SDZ ASM 981 ) - - preclinical pharmacologic profile and skin selectivity. Semin Cutan Med Surg, 2001, 20(4) :233 -241.
-
3Boguniewicz M, Leung DY. Pathophysiologic mechanisms in atopic dermatitis. Semin Cutan Med Surg, 2001, 20(4) :217 -225.
-
4Bergman J, Rico MJ. Tacrolimus clinical studies for atopic dermatitis and other conditions. Semin Cutan Med Surg, 2001, 20(4):250- 259.
-
5Boguniewicz M, Fiedler VC, Raimer S,et al. A randomized, vehiclecontrolled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin lmmunol, 1998, 102(4 Pt 1) :637 -644.
-
6Eichenfield LF, Lucky AW, Boguniewicz M,et al. Safety and efficacy of pimecrolimus (ASM 981 ) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol, 2002, 46 (4) :495 - 504.
-
7Reitamo S, Van Leent E J, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin lmmunol, 2002, 109(3) :539 -546.
-
8Ling MR. Topical tacrolimus and pimecrolimus : future directions. Semin Cutan Med Surg, 2001, 20(4) :268 -274.
-
9Mrowietz U, Graeber M, Brautigam M, et al. The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion. Br J Dermatol, 1998, 139(6) :992 -996.
-
10Zonneveld IM, Rubins A, Jablonska S, et al. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol, 1998, 134(9) :1101 - 1102.
同被引文献12
-
1孙红英,胡宝洋,周国民,俞立英.口腔扁平苔藓病理改变的免疫发病机制研究进展[J].复旦学报(医学版),2005,32(2):247-248. 被引量:6
-
2庞劲凡.口腔扁平苔藓的药物治疗[J].中华老年口腔医学杂志,2006,4(1):45-47. 被引量:10
-
3尚书,唐国瑶.口腔扁平苔藓疗效评价体系的标准化问题[J].临床口腔医学杂志,2006,22(9):570-571. 被引量:7
-
4Setterfield JF, Black MM, Challacombe SJ. The management of oral lichen planus[J]. Clin Exp Dermatol, 2000,2:5 : 176-182.
-
5Carbone M, Goss E, Carrozzo M, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up [J].J Oral Pathol Med, 2003,32: 323-329.
-
6Vente C, Reich K, Rupprecht R, Neumann C. Erosive mucosal lichen planus: response to topical treatment with tacrolimus[J]. Br J Dermatol, 1999,140:338-342.
-
7Ruzicka T, Assmann T, Homey B. Tacrolimus: The drug for the turn of the millennium[J].Arch Dermatol, 1999, 135 (5): 574.
-
8Panhans-Gross A, Novak N, Kraft S, et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus(FK506) [J]. J Allergy Clin Immunol, 2001, 107:345.
-
9Kaliakatsou F, Hodgson TA, Lewsey JD, et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus[J]. J Am Acad Dermatol,2002,46:35--41.
-
10郑际烈.口腔黏膜病诊断学[M].南京:江苏科学技术出版社,1999.9-9.
二级引证文献10
-
1吕晓君.他克莫司软膏治疗糜烂型口腔扁平苔藓的效果观察[J].中国医药导报,2012,9(1):141-142. 被引量:12
-
2付洪,周琦,张筱薇.低浓度他克莫司液治疗慢性糜烂型口腔扁平苔藓的疗效观察[J].口腔医学研究,2013,29(12):1135-1137. 被引量:6
-
3王洪兵,陈刚,易炳东.克莫司软膏治疗糜烂型口腔扁平苔藓效果分析[J].当代医学,2014,20(5):143-144. 被引量:4
-
4杨健.糜烂型口腔扁平苔藓患者予他克莫司治疗的分析研究[J].中国医药指南,2014,12(15):152-152. 被引量:6
-
5谷晓平,李虹.他克莫司软膏治疗口腔扁平苔藓的短期疗效评价[J].中国医药指南,2014,12(27):250-250. 被引量:8
-
6邵延彬.他克莫司联合复方氯己定治疗口腔扁平苔藓的疗效观察[J].药物与人,2015,28(1):48-48.
-
7Chun-lan Gu,Ji-zhi Zhao,Jie Zhang,Hai-tao Dong.Efficacy of Topical Tacrolimus for Erosive Oral Lichen Planus: A Meta-analysis[J].Chinese Medical Sciences Journal,2015,30(4):210-217. 被引量:1
-
8潘宁,王立新,梁凤兴.中医情志护理干预对脂溢性皮炎患者治疗作用的影响分析[J].国际医药卫生导报,2017,23(7):1100-1102. 被引量:6
-
9徐红艳,郭亚丽,姬晓婷,焦惠民.中西医结合与他克莫司软膏治疗糜烂型口腔扁平苔藓疗效对比研究[J].陕西中医,2018,39(10):1441-1443. 被引量:16
-
10路华林,路月亭,邓倩澜,许彦枝,刘铁军.局部应用他克莫司治疗糜烂型口腔扁平苔藓的Meta-分析[J].药物评价研究,2020,43(11):2291-2300. 被引量:2
-
1张少明,方平.局部免疫调节剂他克莫司、吡美莫司在皮肤病的应用[J].海峡药学,2008,20(2):58-60. 被引量:3
-
2高建明,陈志强.新的免疫抑制剂——匹美克莫司[J].国外医学(皮肤性病学分册),2002,28(2):73-76. 被引量:2
-
3汪科,朱学骏.局部免疫调节剂他克莫司、吡美莫司在皮肤病的应用[J].药物不良反应杂志,2005,7(5):345-348. 被引量:19
-
4黄文清,陈建浩.阿维A联合复方甘草酸苷治疗扁平苔藓的近期疗效观察[J].基层医学论坛,2014,18(4):433-434. 被引量:2
-
5崔盘根,陈崑,李锋.灰黄霉素治疗扁平苔藓二例 [J].中华皮肤科杂志,1995,28(5):325-326. 被引量:1
-
6杨小英,李垣君,王慧.他克莫司软膏治疗儿童头面部银屑病的临床研究[J].中国药物与临床,2016,16(8):1185-1186. 被引量:7
-
7赵天恩.新型免疫抑制剂在皮肤科的应用[J].中国皮肤性病学杂志,2003,17(2):137-139. 被引量:1
-
8杨永生,徐金华.特应性皮炎免疫治疗进展[J].临床皮肤科杂志,2007,36(1):59-61. 被引量:2
-
9张冰江.磷酸氯喹口腔黏附片的研制与质量控制[J].中国医院药学杂志,2011,31(14):1181-1183. 被引量:1
-
10韩永红,李淑兰.中西医结合治疗口腔扁平苔藓的临床观察[J].中国伤残医学,2009,17(4):153-154.